TheEdgeResearch
Home / Stocks / KWAC

Kingswood Acquisition Corp. (KWAC)

OTC Financial Services Shell Companies
$13.30 ▲ +0.38%
Market Cap
$46.2M
Sector
Financial Services
Industry
Shell Companies
Beta
0.08
52-Wk Range
10.43-13.5
CEO
Michael Haskel Nessim
Country
US
Currency
USD

Kingswood Acquisition Corp. operates in the Shell Companies industry of the Financial Services sector, headquartered in New York City, NY, US. The stock last traded at $13.30, up 0.38% on the session, giving a market capitalisation of $46.2M. On trailing twelve-month figures it carries a trailing P/E of 78.24, a net margin of 0.0%. Its beta of 0.08 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
78.24
Price / Sales
0.00
Price / Book
-25.55
EV / EBITDA
-9.88
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
-0.33
Current ratio
0.06
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
2
IPO date
2021-02-17
Headquarters
New York City, NY, US
About Kingswood Acquisition Corp.

Kingswood Acquisition Corp. currently lacks substantial business operations of its own. The company's primary objective is to finalize a strategic business combination, which could involve a merger, an exchange of stock, an acquisition of assets, a purchase of shares, a corporate restructuring, or a comparable transaction, with one or more existing entities. It aims to pinpoint an appropriate business target within the wealth management, financial advisory, and investment management sectors, with a geographical scope that includes both the United States and international markets. Kingswood Acquisition Corp. was established in 2020 and maintains its principal office in New York, New York.

Comparable companies

Kingswood Acquisition Corp. is most often compared with the following Financial Services names:

AOAOATMSFRLAIRAAJMTMPTCPTSBAUFFRFYOTA
More research on KWAC
KWAC technical analysis KWAC TheEdge Score Compare against peers
Open full interactive analysis & DCF →